Results 11 to 20 of about 164,448 (358)

ANTISEPTIC INHALATIONS IN PULMONARY DISEASES. [PDF]

open access: greenJournal of the American Medical Association, 1888
In the treatment of pulmonary complaints the tendency at the present time is towards local medication. This arises principally from the general acceptation of the germ theory, which teaches in the main that diseases originate from microorganisms; and the belief that from this it must follow, as a necessity, that these microorganisms must be destroyed ...
S. J. RADCLIFFE
openaire   +4 more sources

Cosmetic Talc–Related Pulmonary Granulomatosis [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2017
Inhalation of cosmetic talc can lead to pulmonary foreign-body granulomatosis, though fewer than 10 cases of inhaled cosmetic talc–related pulmonary granulomatosis have been reported in adults.
Sonia Jasuja MD   +3 more
doaj   +2 more sources

Inhaled Nitric Oxide for High-Altitude Pulmonary Edema [PDF]

open access: bronze, 1996
BACKGROUND. Pulmonary hypertension is a hallmark of high-altitude pulmonary edema and may contribute to its pathogenesis. When administered by inhalation, nitric oxide, an endothelium-derived relaxing factor, attenuates the pulmonary vasoconstriction ...
Urs Scherrer   +9 more
openalex   +4 more sources

Invasive Aspergillus outbreak in inhalation injury: a case presentation and literature review

open access: yesBMC Infectious Diseases, 2022
Background Invasive pulmonary aspergillosis often occurs in patients with poor immune function, who abuse steroids or broad-spectrum antibiotics, or who use intravenous drugs.
Shengli Liu   +3 more
doaj   +1 more source

Early pulmonary response is critical for extra-pulmonary carbon nanoparticle mediated effects: comparison of inhalation versus intra-arterial infusion exposures in mice

open access: yesParticle and Fibre Toxicology, 2017
Background The death toll associated with inhaled ambient particulate matter (PM) is attributed mainly to cardio-vascular rather than pulmonary effects. However, it is unclear whether the key event for cardiovascular impairment is particle translocation ...
Koustav Ganguly   +10 more
doaj   +1 more source

Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection

open access: yesPharmaceutics, 2023
The increased prevalence of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) infection in patients living with cystic fibrosis (CF) is concerning due to a correlation with reduced life expectancy and lack of available treatment options.
Donna M. Konicek   +12 more
doaj   +1 more source

Comparison of the Pulmonary Oxidative Stress Caused by Intratracheal Instillation and Inhalation of NiO Nanoparticles when Equivalent Amounts of NiO Are Retained in the Lung

open access: yesAntioxidants, 2016
NiO nanoparticles were administered to rat lungs via intratracheal instillation or inhalation. During pulmonary toxicity caused by NiO nanoparticles, the induction of oxidative stress is a major factor.
Masanori Horie   +10 more
doaj   +1 more source

Revealing the Pulmonary Surfactant Corona on Silica Nano-particles by Cryo-Transmission Electron Microscopy [PDF]

open access: yesNanoscale Advances 2, 642 - 647 (2020), 2020
When inhaled nanoparticles (NPs) deposit in alveoli, they transit through the pulmonary surfactant (PS), a biofluid made of proteins and phospholipidic vesicles. They acquire a corona reflecting the PS-nanomaterials interaction. Since the corona determines directly the NPs biological fate, the question of its nature and structure is central.
arxiv   +1 more source

The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers [PDF]

open access: yes, 2015
Background: The characteristics of each inhalation maneuver when patients use dry powder inhalers (DPIs) are important, because they control the quality of the emitted dose.
Alaboud A   +8 more
core   +1 more source

Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells [PDF]

open access: yesScientific Reports 10, 19436 (2020), 2020
Pulmonary surfactant forms a sub-micrometer thick fluid layer that covers the surface of alveolar lumen and inhaled nanoparticles therefore come in to contact with surfactant prior to any interaction with epithelial cells. We investigate the role of the surfactant as a protective physical barrier by modeling the interactions using silica-Curosurf ...
arxiv   +1 more source

Home - About - Disclaimer - Privacy